by Jordana Choucair | Mar 9, 2022 | Life Sciences
Pfizer Inc. said it began testing its antiviral pill to treat COVID-19 among children at high risk of severe illness. The study seeks to measure whether the pill can keep newly infected kids out of the hospital. Trial results are expected by the end of the year, and...
by Jordana Choucair | Mar 9, 2022 | Life Sciences
Congress moved to grant the FDA new authority over synthetic nicotine, which some e-cigarette makers have adopted in recent years to avoid the agency’s crackdown on vapes that use nicotine extracted from tobacco. Under the legislation, which is included in the...
by Jordana Choucair | Mar 9, 2022 | Opioid/Substance Use Disorders
Insurers for some of the largest drug makers, distributors, and pharmacies are refusing to pay a $32 billion bill to help cover costs related to opioid addiction. A Delaware Supreme Court ruled in January that Chubb Ltd. didn’t have to pay to defend Rite Aid Corp....
by Jordana Choucair | Mar 9, 2022 | Payers
The Senate passed The Postal Service Reform Act, a sweeping bipartisan bill that will overhaul the US Postal Service’s finances and allow the agency to modernize. The bill would require retired postal employees to enroll in Medicare when eligible, while dropping...
by Jordana Choucair | Mar 9, 2022 | Payers
Amazon Pharmacy announced it is partnering with select Blue Cross and Blue Shield (BCBS) insurers to integrate its drug discount card into their health care coverage. Individuals who receive health insurance through five BCBS plans in Alabama, Florida, Kansas,...
Recent Comments